Co-Diagnostics, Inc. (CODX)Healthcare | Medical Devices | Salt Lake City, United States | NasdaqCM
1.21 USD
-0.05
(-3.968%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.23 +0.02 (1.653%) ⇧ (Aug. 28, 2026, 7:35 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 1:40 a.m. EDT
The investment case for Co-Diagnostics is currently broken by a catastrophic multi-year decline. Despite a recent surge in retail interest and a reverse stock split designed to prop up the share price, the underlying business has lost over 93% of its value since 2017. The company is burning cash aggressively, with operating cash flow in the tens of millions of dollars negative and no path to profitability visible given the negative earnings per share and operating margins. While the stock trades at a fraction of book value, this discount reflects the market's verdict on a failing operation rather than a margin of safety. The recent price spike appears to be a speculative mania detached from reality, exacerbated by a lack of institutional support and heavy put option positioning. With no dividend to provide income and fundamentals deteriorating, this is a clear avoid. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.489765 |
| AutoETS | 0.489778 |
| MSTL | 0.533937 |
| AutoTheta | 0.908893 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 21% |
| H-stat | 37.97 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.124 |
| Excess Kurtosis | -1.46 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.153 |
| Revenue per Share | 0.297 |
| Market Cap | 8,447,396 |
| Forward P/E | -1.46 |
| Beta | 2.88 |
| Website | https://co-dx.com |
As of Aug. 22, 2026, 1:40 a.m. EDT: Speculators are heavily positioned for downside protection, with significant open interest concentrated at the $2.00 strike despite it being out-of-the-money relative to the current price. This suggests a strong expectation that the stock will struggle to breach key resistance levels, while implied volatility remains flat, indicating a lack of anticipated upside catalyst.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.86875 |
| Address1 | 2,401 S. Foothill Drive |
| Address2 | Suite D |
| All Time High | 929.7 |
| All Time Low | 0.94 |
| Ask | 13.0 |
| Ask Size | 1 |
| Audit Risk | 9 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 434,660 |
| Average Daily Volume3 Month | 624,617 |
| Average Volume | 624,617 |
| Average Volume10Days | 434,660 |
| Beta | 2.88 |
| Bid | 0.9144 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | 2.606 |
| City | Salt Lake City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.21 |
| Current Ratio | 1.813 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.285 |
| Day Low | 1.18 |
| Debt To Equity | 14.153 |
| Display Name | Co-Diagnostics |
| Earnings Call Timestamp End | 1,786,653,000 |
| Earnings Call Timestamp Start | 1,786,653,000 |
| Earnings Timestamp | 1,786,651,200 |
| Earnings Timestamp End | 1,794,859,200 |
| Earnings Timestamp Start | 1,794,859,200 |
| Ebitda | -29,090,594 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.196 |
| Enterprise To Revenue | 7.922 |
| Enterprise Value | 5,714,822 |
| Eps Forward | -0.83 |
| Eps Trailing Twelve Months | -25.07 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.1199 |
| Fifty Day Average Change | -0.90989995 |
| Fifty Day Average Change Percent | -0.42921835 |
| Fifty Two Week Change Percent | -86.875 |
| Fifty Two Week High | 46.5 |
| Fifty Two Week High Change | -45.29 |
| Fifty Two Week High Change Percent | -0.9739785 |
| Fifty Two Week Low | 0.94 |
| Fifty Two Week Low Change | 0.27000004 |
| Fifty Two Week Low Change Percent | 0.2872341 |
| Fifty Two Week Range | 0.94 - 46.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,499,866,200,000 |
| Float Shares | 6,135,776 |
| Forward Eps | -0.83 |
| Forward P E | -1.4578314 |
| Free Cashflow | -17,492,616 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 115 |
| Fullday Change | -0.05 |
| Fullday Change Percent | -3.96825 |
| Fullday Price | 1.23 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.43477002 |
| Gross Profits | 313,634 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02014 |
| Held Percent Institutions | 0.105349995 |
| Implied Shares Outstanding | 6,981,319 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,767,312,000 |
| Last Split Factor | 1:30 |
| Long Business Summary | Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah. |
| Long Name | Co-Diagnostics, Inc. |
| Market | us_market |
| Market Cap | 8,447,396 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_60358987 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -47,056,372 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 8,796,461 |
| Number Of Analyst Opinions | 1 |
| Open | 1.26 |
| Operating Cashflow | -27,103,204 |
| Operating Margins | -37.32466 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 801 438 1036 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 1.6528909 |
| Post Market Price | 1.23 |
| Post Market Time | 1,787,960,157 |
| Previous Close | 1.26 |
| Price Hint | 4 |
| Price To Book | 0.46431315 |
| Price To Sales Trailing12 Months | 11.709952 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.293 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.05 |
| Regular Market Change Percent | -3.96825 |
| Regular Market Day High | 1.285 |
| Regular Market Day Low | 1.18 |
| Regular Market Day Range | 1.18 - 1.285 |
| Regular Market Open | 1.26 |
| Regular Market Previous Close | 1.26 |
| Regular Market Price | 1.21 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 156,604 |
| Return On Assets | -0.59634995 |
| Return On Equity | -1.74766 |
| Revenue Growth | 0.02 |
| Revenue Per Share | 0.297 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 6,981,319 |
| Shares Percent Shares Out | 0.058000002 |
| Shares Short | 362,631 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 342,796 |
| Short Name | Co-Diagnostics, Inc. |
| Short Percent Of Float | 0.0591 |
| Short Ratio | 1.0 |
| Source Interval | 15 |
| State | UT |
| Symbol | CODX |
| Target High Price | 4.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 4.0 |
| Target Median Price | 4.0 |
| Total Cash | 3,649,632 |
| Total Cash Per Share | 0.584 |
| Total Debt | 1,799,148 |
| Total Revenue | 721,386 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -25.07 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.93575 |
| Two Hundred Day Average Change | -2.72575 |
| Two Hundred Day Average Change Percent | -0.69256175 |
| Type Disp | Equity |
| Volume | 156,604 |
| Website | https://co-dx.com |
| Zip | 84,109 |